Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 25, 2025Open Access

Comparative Review of LDLT and DDLT Outcomes in Hepatocellular Carcinoma Patients

View Full Paper
Ask AI
Bookmark
Share

Authors

HNHema Manogna NarneTBThangabalan BoovizhikannanJBJaya Lakshmi Bellemkonda

Discussion

Loading...

Member takes

Overview

Comparative review shows survival and recurrence differences between LDLT and DDLT in HCC patients, highlighting critical considerations for transplant choice.

Key Points

  • Overall survival rates differ significantly between LDLT and DDLT in patients with hepatocellular carcinoma, suggesting variable long-term outcomes.
  • This review evaluates data on intention-to-treat overall survival and disease-free survival in liver transplant patients with HCC.
  • Comparative assessment of transplant types looks at both recurrence rates and the impact of graft types on tumor development.
  • Findings encourage informed decision-making for HCC patients seeking transplantation, given the complexities of graft choice.

Cite This Study

Narne et al. (2025) studied this question.

synapsesocial.com/papers/68af5d63ad7bf08b1eae0975https://doi.org/10.38124/ijisrt/25aug905
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Long-term outcomes in deceased versus living donor liver transplantation for hepatocellular carcinoma: a bi-institutional study of 486 cases2025 · 1 citations
  2. 2Outcomes of liver transplantation for hepatocelluler carcinoma from living donor versus deceased donor within University of Southern California San Francisco criteria: a report from Turkey2024 · 2 citations
  3. 3Outcomes of Living-Donor Liver Transplantation for Cholangiocarcinoma Versus Hepatocellular Carcinoma in the United States2025
  4. 4Living-donor liver transplantation in hepatocellular carcinoma with portal-vein tumor thrombosis2025
  5. 5Liver Transplantation for Hepatocellular Carcinoma beyond the Milan Criteria: A Specific Role for Living Donor Liver Transplantation after Neoadjuvant Therapy2024 · 2 citations